BARINTHUS BIOTHERAPEUTICS PLC

Active Altrincham
0 employees website.com
Life sciences and medical technology
B

BARINTHUS BIOTHERAPEUTICS PLC

Founded 22 Mar 2021 Active Altrincham, United Kingdom 0 employees website.com
Life sciences and medical technology

Previous Company Names

VACCITECH PLC 7 Apr 2021 — 6 Nov 2023
VACCITECH LIMITED 7 Apr 2021 — 7 Apr 2021
VACCITECH RX LIMITED 22 Mar 2021 — 7 Apr 2021
Accounts Submitted 25 Apr 2026 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 10 Apr 2026 Next due 4 Apr 2027 11 months remaining
Net assets £130M £17M 2024 year on year
Total assets £160M £8M 2024 year on year
Total Liabilities £30M £9M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BARINTHUS BIOTHERAPEUTICS PLC (13282620), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 22 Mar 2021. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2021–2024)

Cash in Bank

£112.40M

Increased by £829.94k (+1%)

Net Assets

£130.13M

Decreased by £16.69M (-11%)

Total Liabilities

£30.19M

Increased by £8.59M (+40%)

Turnover

£16.14M

Increased by £14.67M (+991%)

Employees

N/A

Debt Ratio

19%

Increased by 6 (+46%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 6May 2016Series B, Seed
Investor 8Jan 2018Series A
Investor 9Jan 2018Series A

Share Capital

Share Capital

Share allotments and capital structure

217 Allotments 13,211,257 Shares £269.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Dec 202518,540£0£0
13 Oct 20253,090£0£0
8 Sept 202552,480£1.574£0
8 Sept 202548,057£15.378£0
8 Sept 202552,480£1.574£0

Officers

Officers

2 active 1 resigned
Status
Dawes, Karen AnneDirectorAmericanUnited States7431 Mar 2021Active
Phillips, Anne Michelle, DrDirectorAmerican,canadianUnited States7231 Mar 2021Active

Shareholders

Shareholders (5)

Bny (nominees) Limited One Canada Square London United Kingdom E14 5al
99.9%
40,339,395
Prudential Credit Opportunities Scsp 1 Rue Hildegard Von Bingen Luxembourg Luxembourg L-1282
0.0%
11,561

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

William James Enright

Ceased 31 Mar 2021

Ceased
Ceased

Group Structure

Group Structure

BARINTHUS BIOTHERAPEUTICS PLC Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
10 Apr 2026Confirmation StatementConfirmation statement made on 21 Mar 2026 with updates
8 Apr 2026OfficersChange to director Dr Anne Michelle Phillips on 27 Jun 2025
24 Jan 2026OfficersAppointment of Mr Alexander Eric Hammacher as director
7 Jan 2026CapitalAllotment of shares (GBP 64,464.222325) on 24 Dec 2025
25 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

10 Apr 2026 Confirmation Statement

Confirmation statement made on 21 Mar 2026 with updates

8 Apr 2026 Officers

Change to director Dr Anne Michelle Phillips on 27 Jun 2025

24 Jan 2026 Officers

Appointment of Mr Alexander Eric Hammacher as director

7 Jan 2026 Capital

Allotment of shares (GBP 64,464.222325) on 24 Dec 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

3 days ago on 25 Apr 2026

Confirmation statement made on 21 Mar 2026 with updates

2 weeks ago on 10 Apr 2026

Change to director Dr Anne Michelle Phillips on 27 Jun 2025

2 weeks ago on 8 Apr 2026

Appointment of Mr Alexander Eric Hammacher as director

3 months ago on 24 Jan 2026

Allotment of shares (GBP 64,464.222325) on 24 Dec 2025

3 months ago on 7 Jan 2026